// App-Quantinova.ai

PO‐099 : Experience of pomalidomide use in refractory and relapsed multiple myeloma within Glasgow, UK

Researchers

Presenter

  • M Rafferty

Principal Investigators

  • L Doherty

  • R Soutar

Medical Centers

  • Department of Rheumatology, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Pomalidomide

  • CC-4047

  • Lenalidomide

  • Thalidomide

  • Bortezomib

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved